• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人多能干细胞中心脏相关基因的无足迹简化 Cas9/CRISPR 编辑。

Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.

机构信息

Department of Stem Cell Biology, Centre of Biomolecular Sciences, University of Nottingham , Nottingham, United Kingdom .

出版信息

Stem Cells Dev. 2018 Mar 15;27(6):391-404. doi: 10.1089/scd.2017.0268. Epub 2018 Mar 12.

DOI:10.1089/scd.2017.0268
PMID:29402189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5882176/
Abstract

Modeling disease with human pluripotent stem cells (hPSCs) is hindered because the impact on cell phenotype from genetic variability between individuals can be greater than from the pathogenic mutation. While "footprint-free" Cas9/CRISPR editing solves this issue, existing approaches are inefficient or lengthy. In this study, a simplified PiggyBac strategy shortened hPSC editing by 2 weeks and required one round of clonal expansion and genotyping rather than two, with similar efficiencies to the longer conventional process. Success was shown across four cardiac-associated loci (ADRB2, GRK5, RYR2, and ACTC1) by genomic cleavage and editing efficiencies of 8%-93% and 8%-67%, respectively, including mono- and/or biallelic events. Pluripotency was retained, as was differentiation into high-purity cardiomyocytes (CMs; 88%-99%). Using the GRK5 isogenic lines as an exemplar, chronic stimulation with the β-adrenoceptor agonist, isoprenaline, reduced beat rate in hPSC-CMs expressing GRK5-Q41 but not GRK5-L41; this was reversed by the β-blocker, propranolol. This shortened, footprint-free approach will be useful for mechanistic studies.

摘要

用人类多能干细胞(hPSC)建模疾病受到阻碍,因为个体间遗传变异对细胞表型的影响可能大于致病突变。虽然“无足迹”Cas9/CRISPR 编辑解决了这个问题,但现有的方法效率低下或耗时冗长。在这项研究中,简化的 PiggyBac 策略将 hPSC 编辑缩短了 2 周,并且只需要一轮克隆扩增和基因分型,而不是两轮,其效率与较长的传统过程相似。通过基因组切割和编辑效率分别为 8%-93%和 8%-67%,在四个与心脏相关的基因座(ADRB2、GRK5、RYR2 和 ACTC1)中都显示出了成功,包括单等位基因和/或双等位基因事件。多能性得以保留,分化为高纯度心肌细胞(CM)的效率也保持在 88%-99%。使用 GRK5 同基因系作为范例,β-肾上腺素受体激动剂异丙肾上腺素对表达 GRK5-Q41 的 hPSC-CM 的刺激会降低心率,但对表达 GRK5-L41 的 hPSC-CM 没有影响;这种影响可以被β受体阻滞剂普萘洛尔逆转。这种简化的、无足迹的方法将有助于进行机制研究。

相似文献

1
Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.人多能干细胞中心脏相关基因的无足迹简化 Cas9/CRISPR 编辑。
Stem Cells Dev. 2018 Mar 15;27(6):391-404. doi: 10.1089/scd.2017.0268. Epub 2018 Mar 12.
2
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.
3
Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R.CRISPR/Cas9 基因编辑介导的 CPVT1 相关 RyR2 突变导致的钙信号转导后果在人诱导多能干细胞衍生心肌细胞中的研究:RyR2-R420Q、F2483I 和 Q4201R 的比较。
Heart Rhythm. 2021 Feb;18(2):250-260. doi: 10.1016/j.hrthm.2020.09.007. Epub 2020 Sep 12.
4
Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.利用CRISPR/Cas9和猪尾巴转座子系统对源自隐性营养不良性大疱性表皮松解症(RDEB)的诱导多能干细胞(iPSC)进行无足迹基因突变校正。
J Dermatol Sci. 2020 Jun;98(3):163-172. doi: 10.1016/j.jdermsci.2020.04.004. Epub 2020 Apr 24.
5
CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.CRISPR/Cas9 基因组编辑:诱导多能干细胞治疗应用的有前途的工具。
Curr Stem Cell Res Ther. 2018;13(4):243-251. doi: 10.2174/1574888X13666180214124800.
6
Modified mRNA-based gene editing reveals sarcomere-based regulation of gene expression in human induced-pluripotent stem cell-derived cardiomyocytes.基于修饰 mRNA 的基因编辑揭示了人类诱导多能干细胞衍生的心肌细胞中基于肌节的基因表达调控。
Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113378. doi: 10.1016/j.intimp.2024.113378. Epub 2024 Oct 17.
7
CRISPR/Cas9 gene-editing strategies in cardiovascular cells.CRISPR/Cas9 基因编辑策略在心血管细胞中的应用。
Cardiovasc Res. 2020 Apr 1;116(5):894-907. doi: 10.1093/cvr/cvz250.
8
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.利用 CRISPR-Cas9 RNP 和 AAV6 供体介导的同源重组对人多能干细胞进行高效、无标记的基因组编辑。
Cell Stem Cell. 2019 May 2;24(5):821-828.e5. doi: 10.1016/j.stem.2019.04.001.
9
CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca signaling.CRISPR/Cas9 基因编辑技术在人类干细胞来源的心肌细胞中的 RyR2 研究为研究功能失调的 Ca 信号提供了一种新方法。
Cell Calcium. 2018 Jul;73:104-111. doi: 10.1016/j.ceca.2018.04.009. Epub 2018 Apr 27.
10
Genome editing of hPSCs: Recent progress in hPSC-based disease modeling for understanding disease mechanisms.人类多能干细胞的基因组编辑:基于 hPSC 的疾病建模在理解疾病机制方面的最新进展。
Prog Mol Biol Transl Sci. 2021;181:271-287. doi: 10.1016/bs.pmbts.2021.01.020. Epub 2021 Feb 24.

引用本文的文献

1
A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells.基于细胞的优化方法,用于快速高效地编辑人类多能干细胞中的基因。
Int J Mol Sci. 2023 Jun 17;24(12):10266. doi: 10.3390/ijms241210266.
2
Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes.基于 CRISPR 的工具在人诱导多能干细胞心肌细胞中的基因调控。
Stem Cell Rev Rep. 2023 May;19(4):886-905. doi: 10.1007/s12015-023-10506-4. Epub 2023 Jan 19.
3
Selecting for CRISPR-Edited Knock-In Cells.筛选 CRISPR 编辑的敲入细胞。

本文引用的文献

1
A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia.关注儿茶酚胺能多形性室性心动过速的药物治疗
Mini Rev Med Chem. 2018;18(6):476-482. doi: 10.2174/1389557517666170707100923.
2
CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection.CRISPR/Cas9介导的基因敲除筛选以及通过全基因组测序进行的靶点鉴定揭示了小RNA病毒感染所需的宿主基因。
J Biol Chem. 2017 Jun 23;292(25):10664-10671. doi: 10.1074/jbc.M117.782425. Epub 2017 Apr 26.
3
Mechanisms of precise genome editing using oligonucleotide donors.
Int J Mol Sci. 2022 Oct 7;23(19):11919. doi: 10.3390/ijms231911919.
4
Fluorescence Spectroscopy of Low-Level Endogenous β-Adrenergic Receptor Expression at the Plasma Membrane of Differentiating Human iPSC-Derived Cardiomyocytes.分化中的人诱导多能干细胞衍生心肌细胞膜上低水平内源性β-肾上腺素能受体表达的荧光光谱分析
Int J Mol Sci. 2022 Sep 8;23(18):10405. doi: 10.3390/ijms231810405.
5
Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.GRK5/ACTC1的共过表达与上皮性卵巢癌的临床参数及不良预后相关。
Front Mol Biosci. 2022 Feb 9;8:785922. doi: 10.3389/fmolb.2021.785922. eCollection 2021.
6
Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo.心肌细胞细胞外囊泡在肥厚型心肌病中的转录组分析揭示了差异 snoRNA 货物。
Stem Cells Dev. 2021 Dec 15;30(24):1215-1227. doi: 10.1089/scd.2021.0202.
7
CRISPR/Cas9-mediated generation and analysis of N terminus polymorphic models of βAR in isogenic hPSC-derived cardiomyocytes.CRISPR/Cas9介导的人诱导多能干细胞衍生心肌细胞中β肾上腺素能受体N端多态性模型的构建与分析
Mol Ther Methods Clin Dev. 2020 Oct 27;20:39-53. doi: 10.1016/j.omtm.2020.10.019. eCollection 2021 Mar 12.
8
Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy.线粒体DNA:调控肥厚型心肌病潜在基因修饰因子的热点区域
J Clin Med. 2020 Jul 23;9(8):2349. doi: 10.3390/jcm9082349.
9
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.肥厚型心肌病的同基因模型揭示了不同的表型和机制驱动的治疗方法。
J Mol Cell Cardiol. 2020 Aug;145:43-53. doi: 10.1016/j.yjmcc.2020.06.003. Epub 2020 Jun 10.
10
Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits.具有肥厚型心肌病/LVNC 相关 ACTC1 E99K 突变的同基因 hiPSC-CMs 揭示了不同的功能缺陷。
Stem Cell Reports. 2018 Nov 13;11(5):1226-1243. doi: 10.1016/j.stemcr.2018.10.006. Epub 2018 Nov 1.
使用寡核苷酸供体进行精确基因组编辑的机制。
Genome Res. 2017 Jul;27(7):1099-1111. doi: 10.1101/gr.214775.116. Epub 2017 Mar 29.
4
Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.通过 Cas9/CRISPR 和 piggyBac 技术的整合实现高效、无足迹的人类 iPSC 基因组编辑。
Nat Protoc. 2017 Jan;12(1):88-103. doi: 10.1038/nprot.2016.152. Epub 2016 Dec 8.
5
Two Distinct Pathways Support Gene Correction by Single-Stranded Donors at DNA Nicks.两条不同途径支持单链供体在DNA切口处进行基因校正。
Cell Rep. 2016 Nov 8;17(7):1872-1881. doi: 10.1016/j.celrep.2016.10.049.
6
The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.染色质动力学对人类细胞中Cas9介导的基因组编辑的影响
ACS Synth Biol. 2017 Mar 17;6(3):428-438. doi: 10.1021/acssynbio.5b00299. Epub 2016 Nov 17.
7
Insertion of a knockout-first cassette in Ampd1 gene leads to neonatal death by disruption of neighboring genes expression.在Ampd1基因中插入敲除优先盒会因邻近基因表达的破坏导致新生小鼠死亡。
Sci Rep. 2016 Oct 24;6:35970. doi: 10.1038/srep35970.
8
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.人类成体造血干/祖细胞中镰状突变的无筛选基因组编辑。
Sci Transl Med. 2016 Oct 12;8(360):360ra134. doi: 10.1126/scitranslmed.aaf9336.
9
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?将人多能干细胞来源的心肌细胞整合到安全药理学中:时机是否已经成熟?
Br J Pharmacol. 2017 Nov;174(21):3749-3765. doi: 10.1111/bph.13577. Epub 2016 Sep 20.
10
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.利用 CRISPR/Cas9 高效引入特定的纯合子和杂合子突变。
Nature. 2016 May 5;533(7601):125-9. doi: 10.1038/nature17664. Epub 2016 Apr 27.